A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis

Korean Journal of Laboratory Medicine

Volumn 28, Issue 1, 2008, Pages 39-45

  Cho, Sun Young ^a   Kang, So Young ^a   Lee, Hee Joo ^b   Lee, Woo In ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Anti cyclic citrullinated peptide (CCP) antibody; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; RHEUMATOID ARTHRITIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; REAGENT KITS, DIAGNOSTIC; RHEUMATOID FACTOR; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 58149105691     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2008.28.1.39     Document Type: Article

References (18)

1. Kasper DL, Fauci AS, et al. eds. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill, 2004:1968-76.
2. Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004;6:R137-41.
3. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000;2:236-43. (Pubitemid 32223739)
4. Choi SW, Lim MK, Shin DH, Lim CH, Shim SC. Diagnostic performance of the anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Korean J Lab Med 2003;23:132-8.
5. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63. (Pubitemid 30368225)
6. Vallbracht I and Helmke K. Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Autoimmun Rev 2005; 4:389-94. (Pubitemid 41080076)
7. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined stepdown prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18. (Pubitemid 27351112)
8. Rose NR, Hamilton RG, et al. eds. Manual of clinical laboratory immunology. 6th ed. Washington: ASM press, 2002:659-64.
9. Choi SW, Lim MK, Shin DH, Park JJ, Shim SC. Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis. J Korean Med Sci 2005;20:473-8.
10. Kang HJ, Seo YI, Lee YK, Cho HC. Diagnostic usefulness of the anticyclic citrullinated peptide antibodies for rheumatoid arthritis. J Korean Rheum Assoc 2003;10:117-25.
11. Kim KH. Diagnostic role of the anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Korean J Lab Med 2003;23:405-10.
12. Kaplan LA, Pesce A, et al. eds. Clinical chemistry : theory, analysis, correlation. 3rd ed. St.Louis: Mosby, 1996:427-8.
13. Lee DM and Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003;62:870-4. (Pubitemid 37026499)
14. Vallbracht I, Rieber J, Oppermann M, Forger F, Siebert U, Helmke K. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 2004;63:1079-84. (Pubitemid 39120358)
15. Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L, et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 2005;64:1199-204. (Pubitemid 41113357)
16. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006;65:845-51.
17. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003;62:120-6. (Pubitemid 36135386)
18. Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-5.